Daniel P. Petrylak, MD

Professor of Medicine (Medical Oncology) and of Urology; Professor; Co-Director, Signal Transduction Research Program

Departments & Organizations

Cancer Center, Yale: Prostate and Urologic Cancers Program | Signal Transduction

General Urology

Medical Oncology: Subset Medical Oncology Faculty

Medical Oncology

Office of Student Research

Yale Medical Group


Dr. Petrylak’s national leadership on clinical trials for men with prostate and bladder cancer enables Smilow to bring new treatment options to patients in Connecticut, especially those with hormone refractory prostate cancer and advanced stage disease. Dr. Petrylak currently serves as the Principal Investigator or co-Principal Investigator on seven Southwest Oncology Group (SWOG) clinical trials for genitourinary cancers, and is currently head of the advanced bladder section of SWOG.

Education & Training

MD Case Western Reserve University School of Medicine (1985)
Fellowship Memorial Sloan-Kettering Cancer Center
Residency Bronx Municipal Hospital
Internship Bronx Municipal Hospital
Board Certification AB of Internal Medicine (1993)

Edit this profile

Contact Info

Daniel P. Petrylak, MD
Patient Care Location
Smilow Cancer Hospital at Yale-New HavenYale-New Haven Hospital
20 York Street, Ste North Pavilion 4

New Haven, CT 06510
Mailing Address
PO Box 208032
New Haven, CT 06520-8032

Curriculum Vitae